BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2016
View Archived Issues
GeoVax gives update on its Zika vaccine program
Read More
Enterome signs exclusive worldwide license agreement with Vertex for IBD therapeutical agents
Read More
CytoDyn reports complete viral load suppression in ongoing PRO-140 monotherapy extension study
Read More
Protein Sciences, Sinergium Biotech and the Mundo Sano collaborate on Zika vaccine
Read More
Treatment completed in BioSight's phase I/IIa trial of Astarabine
Read More
Sucampo to discontinue development of cobiprostone in PPI-refractory NERD/sGERD
Read More
Bristol-Myers Squibb discloses kallikrein B inhibitors
Read More
Bristol-Myers Squibb reports AP2-associated protein kinase 1 inhibitors
Read More
Merck & Co. introduces IRAK-4 inhibitors
Read More
Xuzhou Yes Biotechnology divulges TNF-alpha-binding antibodies
Read More
Lpath completes phase I study of Lpathomab
Read More
Preclinical development of Trk-A inhibitor GVK-904
Read More
First in-human trial evaluating MVT-5873 in CA19-9-positive malignancies
Read More
Assembly Biosciences discloses novel CpAM candidate
Read More
BARDA awards contract to Basilea for phase III development of ceftobiprole
Read More
Arbutus Biopharma presents novel small-molecule inhibitor of HBV capsid assembly
Read More
Astex and Genentech collaborate to study guadecitabine with atezolizumab in AML
Read More
Dyanavel XR launched in the U.S. for the treatment of children with ADHD
Read More
Elbasvir and grazoprevir granted priority review in Japan
Read More
Tecfidera filed for approval for the prevention of multiple sclerosis in Japan
Read More
MedImmune gains IND approval to begin phase I trial of anti-ILT7 antibody
Read More
ITPase activity linked to tolerability of combination antiretroviral regimens for HIV infection
Read More
Arno Therapeutics focuses onapristone development on mCRPC
Read More
YKP-3089 reduces frequency of partial-onset seizures and achieves seizure freedom as adjunct therapy
Read More